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Urbanization, ethnicity and cardiovascular risk in
a population in transition in Nakuru, Kenya: a
population-based survey
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Abstract
Background: Cardiovascular disease (CVD) is the leading cause of death among older people in Africa. This study
aimed to investigate the relationship of urbanization and ethnicity with CVD risk markers in Kenya.
Methods: A cross-sectional population-based survey was carried out in Nakuru Kenya in 2007-2008. 100 clusters of
50 people aged ≥50 years were selected by probability proportionate to size sampling. Households within clusters
were selected through compact segment sampling. Participants were interviewed by nurses to collect socio-
demographic and lifestyle information. Nurses measured blood pressure, height, weight and waist and hip
circumference. A random finger-prick blood sample was taken to measure glucose and cholesterol levels.
Hypertension was defined as systolic blood pressure (SBP) ≥140 mm Hg, or diastolic blood pressure (DBP) ≥90 mm
Hg or current use of antihypertensive medication; Diabetes as reported current medication or diet control for
diabetes or random blood glucose level ≥11.1 mmol/L; High cholesterol as random blood cholesterol level ≥5.2
mmol/L; and Obesity as Body Mass Index (BMI)≥30 kg/m2.
Results: 5010 eligible subjects were selected, of whom 4396 (88%) were examined. There was a high prevalence of
hypertension (50.1%, 47.5-52.6%), obesity (13.0%, 11.7-14.5%), diabetes (6.6%, 5.6-7.7%) and high cholesterol (21.1%,
18.6-23.9). Hypertension, diabetes and obesity were more common in urban compared to rural groups and the
elevated prevalence generally persisted after adjustment for socio-demographic, lifestyle, obesity and cardiovascular
risk markers. There was also a higher prevalence of hypertension, obesity, diabetes and high cholesterol among
Kikuyus compared to Kalenjins, even after multivariate adjustment. CVD risk markers were clustered both across the
district and within individuals. Few people received treatment for hypertension (15%), while the majority of cases
with diabetes received treatment (68%).
Conclusions: CVD risk markers are common in Kenya, particularly in urban areas. Exploring differences in CVD risk
markers between ethnic groups may help to elucidate the epidemiology of these conditions.
Background
Infectious diseases are still the principal cause of death
in Africa [1]. However, among older people coronary
heart disease (CHD) and stroke are emerging as the
leading cause, responsible for more than a quarter of
deaths in people 60 years and over in Africa [2,3]. This
represents a dramatic shift as CHD was virtually
unknown in Africa until recently [4,5]. Stroke is particu-
larly common in Africa in comparison to CHD [6], and
stroke mortality rates and prevalence of disabling stroke
in most African countries are comparable to levels seen
in high-income countries [7-9]. African countries are
therefore experiencing a shift in the epidemiological
transition [10], while retaining a high burden of infec-
tious diseases.
The rise in cardiovascular disease (CVD) is linked to the
increase in hypertension, diabetes, obesity, and high cho-
lesterol observed in Africa in recent years. Obesity [11-14]
and hypertension [11,15-17] are now common throughout
Africa, particularly in urban areas [11,12,14,16,17]. The
number of people with diabetes in Sub-Saharan Africa is
expected to more than double between 2000 and 2030
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[18], and diabetes is particularly common in urban areas
[19]. Urbanisation is therefore a key feature in the rise of
CVD. Currently 40% of Africans live in urban areas [20],
and it is estimated that by 2030 half of Africans will live
in urban areas. The Kenyan Luo Migration Study ele-
gantly demonstrated the impact of rural-urban migration
on CVD risk in Africa [21]. Rural migrants to Nairobi
experienced a rise in systolic and diastolic blood pressure
after only one month of migration. In contrast, the effect
of rural-urban migration on blood pressure was not
observed in a recent study in Tanzania, even though phy-
sical activity levels fell and weight increased after migra-
tion [22]. The discrepancy between the two studies may
be because the rural-urban contrast in sodium intake
was smaller in the Tanzanian compared to the Kenyan
study (personal communication). The impact of rural-
urban migration on health may therefore vary depending
on setting.
People of African origin may be particularly vulnerable
to hypertension. The prevalence of hypertension is high
among people of African origin compared to Whites
independent of BMI [23-25], and there is a younger age
at onset in Africa [15] and among people of African des-
cent [26]. Although the same risk markers are largely
responsible for myocardial infarction (MI) across the
globe [27], hypertension was associated with a higher
MI risk in the Black African group than in the overall
INTERHEART group [28]. There may also be greater
difficulty in achieving control [26], and more aggressive
presentation [26,29] and progress [28] of hypertension
among people of African origin. This vulnerability may
be due to lifestyle factors, but may also be influenced by
ethnicity which varies widely within Africa and is linked
to substantial heterogeneity in body composition [14],
which may exert important metabolic effects [30].
The aim of this study was to investigate the relation-
ship of urbanization and ethnicity with the prevalence of
obesity, hypertension, diabetes and high cholesterol in a
study of elderly people in Nakuru district, Kenya.
Methods
Settings and population
Nakuru district has a population of 1.2 million, one
third of which is urban. Nakuru is broadly representa-
tive of Kenya in terms of ethnic diversity and economic
activities. The two dominant ethnic groups are Kikuyus
and Kalenjins. The Kikuyu are related to other Bantu-
speaking peoples of East Africa while Kalenjins are of
Nilotic origin.
During Jan 2007- Dec 2008, a sample of 100 clusters
of 50 people aged ≥50 years were selected across
Nakuru district through probability proportionate to
size sampling, using the electoral role as the sampling
frame. Clusters were classed as “rural” or “urban” using
the classification of the district statistical office. House-
holds were selected within clusters through modified
compact segment sampling [31]. The village leaders pro-
duced a sketch map of the polling area. The polling area
was divided into segments each including approximately
50 people aged ≥ 50 years. One segment was chosen at
random by drawing lots and all households in the seg-
ment were included in the sample sequentially, until 50
people aged ≥50 years were identified. If the segment
did not include 50 people aged ≥50 years then another
segment was chosen at random and sampling continued.
The enumeration team visited households, assisted by
a village guide, and invited all eligible participants aged
≥50 years to the examination clinic which would be
held at a convenient place in the cluster over the subse-
quent two days. Eligible participants were defined as
those aged ≥50 years resident in the cluster (i.e. living
there at least 6 months per year) who had slept in the
house either the night before or were planning on sleep-
ing in the house that night. If an eligible person was
absent then the survey team revisited the household at
least two times.
Examination clinic
Interviews
Participants were interviewed by trained nurses. Infor-
mation was collected on demographic data, education
and assets (building materials of the house - type of
walls, roof, floor and toilet; ownership of household
assets - radio, TV, fridge, phone, cupboard, sofa set,
sewing machine, table, bicycle and vehicle; animal own-
ership - cows, sheep/goats). People were asked whether
their mother tongue was “Kikuyu”, “Kalenjin” or other.
For simplicity, people will be classified as “Kikuyu” and
“Kalenjin” in the text. Information was also collected on
health behaviour (smoking, alcohol use) and health sta-
tus (diagnosis of diabetes or hypertension, family history
and their treatment).
Physical examination
A nurse recorded the blood pressure of participants
three times on the right arm of the participant, at least
five minutes apart after an initial period of five minutes
of rest using the Omron digital automatic monitor
(model HEM907). A medium cuff size was used (to fit
arms 22 to 32 cm). The average of the last two readings
was used as the measures of systolic and diastolic blood
pressure (to nearest 1 mm Hg). A random finger-prick
blood sample was taken to measure glucose (Accutrend
GC system) and cholesterol levels (Accutrend GC sys-
tem). The technical data from the company asserts that
precision is <3% for glucose and <5% for cholesterol
[32]. Weight was measured to the nearest kg using stan-
dard scales to the nearest 0.1 kg (Seca 761 scales) after
the participant had removed all heavy clothing and
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shoes. Height was measured to the nearest cm while the
participant stood without shoes using a standardized
stadiometer (Leicester Height Measure). For weight and
height the average of two readings was recorded. Waist
and hip circumferences were measured with a tape. The
waist circumference was measured at umbilicus level in
mid-expiration to the nearest 0.1 cm. The hip circum-
ference was measured at the point of largest gluteal cir-
cumference to the nearest 0.1 cm.
Training
The examination team received three weeks of training.
Inter observer variation (IOV) was assessed during the
training weeks at the Nakuru Provincial General Hospi-
tal. IOV on anthropometric variables were done by
repeat measuring of 50 subjects by the two nurses. The
level of agreement required was to the nearest 1 cm for
circumferences and height, and to the nearest 0.5 kg for
weight. The staff were retrained or replaced if IOV
scores indicated poor comparability (kappa < 0.5).
Statistical analysis
Statistical analyses were undertaken using the SAS sta-
tistical package (version 9.2). The four CVD risk mar-
kers considered were hypertension, diabetes, high
cholesterol and obesity. Hypertension was defined as
systolic blood pressure (SBP) was ≥140 mm Hg, or dia-
stolic blood pressure (DBP) ≥90 mm Hg or current use
of antihypertensive medication [33]. Diabetes was
defined as reported current medication (tablets or insu-
lin) or diet control for diabetes or random blood glucose
level ≥11.1 mmol/L [34]. People were categorized as
having high cholesterol if their random blood choles-
terol level was ≥5.2 mmol/L [35]. Obesity was defined as
Body Mass Index (BMI)≥30 kg/m2 [36]. Prevalence esti-
mates for the four CVD risk markers were calculated
taking account of the design effect (DEFF) in estimating
the confidence intervals. The DEFF was not taken into
account for other analyses. A relative index of socio-
economic status (SES) was calculated based on building
materials of the house, ownership of ten household
assets and education status using principal components
analysis [37]. The derived index was divided into quar-
tiles from poorest to least poor.
We assessed the association between rural-urban sta-
tus and, in turn, hypertension, diabetes, high cholesterol
and obesity through logistic regression models. The
models were adjusted in turn for, a) for age (50-59, 60-
69, 70-79, ≥80) and sex, b) age, sex and socio-demo-
graphic factors (SES score in quartiles), c) age, sex, BMI
(<20, 20-25, >25-30, ≥30), waist hip ratio (WHR - in
quartiles), smoking (current, former, never) and alcohol
(current, former, never), d) age, sex, diabetes and high
cholesterol (as appropriate) and e) fully adjusted model.
These models were repeated assessing the association
between the four CVD markers and Kikuyu or Kalenjin
ethnicity, adjusting for urban status in models b and e.
We included an interaction factor in the logistic regres-
sion models for ethnicity to assess whether there was an
interaction between ethnicity and urban status in the
relationship with CVD risk markers. We assessed
the proportion of people receiving medical treatment
among people who were defined as “hypertensive”, and
attempted to identify predictors of treatment status
through logistic regression models. This was repeated
for people with diabetes.
We assessed whether the CVD risk markers were clus-
tered geographically by calculating the DEFF for each of
the variables. We assessed whether there was clustering
of the CVD risk markers within individuals. To do this,
we derived expected frequencies of co-occurrence of
risk markers (hypertension, diabetes, high cholesterol
and obesity) from none through to four risk markers by
combining probabilities, assuming a binomial distribu-
tion and independence between them [38]. We esti-
mated observed to expected ratios for all participants
and then separately for urban and rural groups and for
Kikuyu and Kalenjin groups. We considered that there
was clustering if the observed:expected ratios were high
for no risk markers, low for one risk marker and high
for three or more risk markers. We calculated chi-
square statistics with 3 degrees of freedom to test the
significance of the overall distribution of expected and
observed counts within each group.
Ethical approval
Ethical approval for this work was granted by the Lon-
don School of Hygiene & Tropical Medicine and The
Kenya Medical Research Institute Ethical Committee
and Nakuru District Health Management Team. Infor-
med consent was obtained from the subjects. All people
with other treatable conditions were referred for appro-
priate treatment.
Results
We examined 4,396 (88%) of the 5,010 people invited.
Among those examined 1,437 (33%) lived in urban and
2,959 (67%) in rural areas (Table 1). Urban dwellers
were younger, and had higher education levels and asset
scores than rural dwellers. They were also more likely to
be smokers and obese, than rural participants. Kikuyus
made up 63% of the sample and Kalenjins 23% while
the remaining 15% consisted of other language speakers.
Kikuyus were more likely than Kalenjins to live in urban
areas or to be female, and they had higher levels of edu-
cation and higher SES scores. Kikuyus were less likely to
be current smokers or consumers of alcohol. Kikuyus
were significantly shorter yet heavier than Kalenjins
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among both men (166 cm vs 168 cm, 64 kg vs 60 kg)
and women (156 cm vs 158 cm, 62 kg vs 58 kg) and
consequently had higher BMIs.
There was a high prevalence of hypertension (50.1%,
47.5-52.6%), obesity (13.0%, 11.7-14.5%), diabetes (6.6%,
5.6-7.7%) and high cholesterol (21.1%, 18.6-23.9%).
Mean SBP and DBP were higher in urban than rural
areas among both men and women (Table 2). Similarly,
mean glucose and cholesterol levels and markers of
obesity were higher in urban than rural men and this pat-
tern was generally repeated among women. The preva-
lence of obesity generally fell sharply with age (Figure 1).
The prevalence of hypertension increased steadily with
age, and was consistently higher in urban than rural areas
(Figure 2). The association between prevalence and age
were less clear for the diabetes (Figure 3) and high cho-
lesterol (data not shown). Meanwhile, SBP increased with
age while DBP decreased, and both remained higher for
people from urban than rural areas across the age groups
(Figure 4). Kikuyus had higher SBP than Kalenjins, but
the differences were less clear for DBP (Table 3). Kikuyus
also had higher levels of glucose, cholesterol, BMI and
waist circumference but not of WHR. Kikuyus were more
likely to be hypertensive, obese or diabetic in all age
groups (Figure 5, 6, 7, 8).
The odds of hypertension was higher in urban than
rural groups after adjustment for age and sex (Odds
ratio - OR = 1.7, 95% CI = 1.5-1.9) (Table 4). The
Table 1 Demographic characteristics and health behavior comparing urban and rural participants, and Kikuyus and
Kalenjins
Urban
(n = 1437)
Rural
(n = 2959)
Age and sex adjusted
OR (95% CI)
Kikuyu
(n = 2760)
Kalenjin
(n = 1015)
Age and sex adjusted
OR (95% CI)
Age
50-59 57% 38% Baseline 40% 40% Baseline
60-69 26% 31% 0.6 (0.5-0.7) 32% 28% 1.2 (1.0-1.4)
70-79 11% 20% 0.4 (0.3-0.5) 17% 20% 0.9 (0.7-1.1)
≥80 6% 11% 0.4 (0.3-0.5) 10% 11% 0.9 (0.7-1.2)
Sex
Men 49% 47% Baseline 44% 53% Baseline
Women 51% 53% 0.9 (0.8-1.0) 56% 47% 1.4 (1.2-1.6)
Language
Kikuyu 65% 62% Baseline
Kalenjin 6% 31% 0.2 (0.1-0.2)
Other 29% 7% 3.3 (2.7-4.0)
Urban 931 (34%) 84 (8%) Baseline
Rural 1812 (66%) 924 (92%) 5.7 (4.5-7.2)
Education
Any 79% 61% 1.4 (1.3-1.6) 71% 51% 1.9 (1.7-2.1)
None 21% 39% Baseline 29% 49% Baseline
SES score
1 (poorest) 8% 33% Baseline 20% 44% Baseline
2 14% 31% 1.6 (1.2-2.0) 26% 27% 2.4 (2.0-2.9)
3 24% 26% 3.1 (2.5-3.9) 27% 20% 3.4 (2.8-4.2)
4 (richest) 54% 11% 16.7 (13.3-21.1) 26% 9% 7.8 (6.0-10.2)
Smoking
Never 70% 70% Baseline 69% 73% Baseline
Current 7% 8% 1.4 (1.1-1.8) 8% 6% 0.5 (0.3-0.6)
Former 23% 22% 1.1 (0.9-1.3) 24% 20% 2.0 (1.6-2.5)
Alcohol
Never 41% 38% Baseline 45% 23% Baseline
Former 41% 46% 0.9 (0.7-1.0) 44% 49% 0.4 (0.3-0.5)
Current 18% 17% 0.9 (0.7-1.1) 11% 28% 0.2 (0.1-0.2)
BMI cat
Underweight 8% 17% 0.7 (0.5-0.9) 12% 21% 0.7 (0.6-0.9)
Normal 41% 54% Baseline 48% 56% Baseline
Overweight 30% 19% 2.1 (1.7-2.4) 25% 15% 1.9 (1.5-2.3)
Obese 20% 10% 2.8 (2.3-3.5) 14% 8% 2.0 (1.5-2.6)
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association was weakened after adjustment for SES mar-
kers and for obesity, smoking and alcohol, but not after
adjustment for diabetes and cholesterol. In the fully
adjusted model the odds of hypertension remained
higher among urban compared to rural dwellers (1.3,
1.1-1.5). People in urban areas were also more likely to
have diabetes (2.3, 1.8-2.9). The increased odds was
reduced after adjustment for socio-demographic vari-
ables, though adjustment for other CVD risk markers
had less effect. In the fully adjusted model the odds of
diabetes was no longer elevated in urban compared to
rural participants (1.3, 0.9-1.7). No clear association was
apparent between the odds of high cholesterol and
urban status. The pattern for the association between
obesity and urban residence was similar to that for
diabetes.
The odds of hypertension was higher among Kikuyus
compared to Kalenjins (1.6, 1.4-1.8) (Table 5). The asso-
ciation persisted after adjustment for socio-demographic
variables and other CVD risk markers (1.4, 1.2-1.7).
Similarly, Kikuyus were more likely to have diabetes and
high cholesterol, and these associations were not fully
explained by adjustment for potential confounders.
Kikuyus were more likely to be obese compared to
Kalenjin, but not in models adjustment for SES and
urban status. For all four risk markers, the biggest
change in the association occurred after adjustment for
SES and urban status.
There was no interaction between urban status and
ethnicity for these conditions after adjustment for age
and sex (data not shown).
There was substantial variation in the prevalence of
hypertension (range 17-77% (DEFF = 2.9) diabetes
(range = 0-26%; DEFF = 1.8), high cholesterol (range
0-51.2%, DEFF = 4.3) and obesity (range 0-40%, DEFF =
1.8) between clusters. The variation was similar in rural
and urban areas and among Kikuyus and Kalenjins.
Few people had 3-4 (4.5%) or 2 (18.5%) risk markers
and the vast majority of the population had no (37.0%)
or one (40.1%) risk marker (Table 6). Generally rural
dwellers and Kalenjins had fewer risk factors than urban
dwellers and Kikuyus. There was a greater than expected
Table 2 Means (and standard error) of cardiovascular risk markers, by gender and urban-rural status
Urban-rural comparison
Men Women
No. Urban/Rural Urban Rural Age adjusted p-value No. Urban/Rural Urban Rural Age adjusted p-value
Mean SBP 705/1395 143 (24) 140 (24) <0.0001 726/1550 143 (26) 140 (25) <0.0001
Mean DBP 705/1395 84 (14) 81 (13) <0.0001 726/1550 86 (14) 83 (13) <0.0001
Glucose 692/1373 5.8 (2.9) 4.8 (2.0) <0.0001 704/1527 5.7 (2.8) 5.1 (2.3) <0.0001
Cholesterol 698/1342 4.5 (0.9) 4.3 (0.9) 0.0004 718/1514 4.8 (0.9) 4.7 (1.0) 0.08
BMI 700/1385 24 (6) 22 (4) <0.0001 718/1543 27 (6) 24 (6) <0.0001
Waist 703/1390 92 (13) 86 (11) <0.0001 719/1546 96 (13) 89 (13) <0.0001
WHR 703/1390 0.92 (0.07) 0.92 (0.06) 0.0009 718/1546 0.89 (0.06) 0.89 (0.08) 0.34
Figure 1 Age trends in obesity by urban status.
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frequency of people with 3-4 risk markers than would be
expected by chance, and to a lesser extent a higher fre-
quency of people with no risk markers, except among
Kalenijn. Together, this provides evidence for clustering
of risk markers within individuals, which was more
apparent among rural versus urban dwellers, and among
Kalenjins compared to Kikuyus.
Among people with hypertension, only 323 (15%)
received drug treatment, 38 (2%) received diet treatment
and 7 traditional medicine treatment (0.3%) (Table 7).
Among those on drug treatment, only 98 (29%) had
controlled hypertension. A far higher proportion of peo-
ple with diabetes were receiving treatment (68%), which
included insulin (n = 32), tablets (n = 143) and/or diet
control (n = 43). A further 10 received traditional treat-
ment. For both hypertension and diabetes, treatment
was more among people living in urban areas, women,
older people and those with a higher SES score. Kalen-
jins were less likely to receive treatment for hyperten-
sion than Kikuyus (0.5, 0.3-0.8), but there was no
difference for diabetes.
Sensitivity analysis
We assessed the impact of lowering the threshold ran-
dom blood glucose level for the classification of “dia-
betes”. Lowering the threshold to ≥10 mmol/L added an
additional 13 cases to the original 283 cases (revised
prevalence 6.9%), for ≥9 mmol/L this was 41 cases
Figure 2 Age trends in hypertension by urban status.
Figure 3 Age trends in diabetes by urban status.
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Figure 4 Age trends in systolic and diastolic blood pressure by urban status.
Table 3 Means (and standard error) of cardiovascular risk markers, by gender and ethnicity
Kikuyu-Kalenjin comparison
Men Women
No. Kikuyu/Kalenjin Kikuyu Kalenjin Age adjusted
p-value
No. Kikuyu/Kalenjin Kikuyu Kalenjin Age adjusted
p-value
Mean SBP 1218/535 142 (24) 139 (23) 0.007 1531/473 142 (26) 136 (24) <0.0001
Mean DBP 1218/535 81 (13) 81 (13) 0.85 1531/473 84 (14) 82 (13) 0.02
Glucose 1209/515 5.5 (2.6) 4.4 (1.7) <0.0001 1516/449 5.5 (2.6) 4.9 (2.0) <0.0001
Cholesterol 1177/524 4.4 (1.0) 4.2 (0.7) <0.0001 1496/466 4.8 (1.0) 4.5 (1.0) <0.0001
BMI 1207/534 23 (5) 21 (4) <0.0001 1519/469 26 (6) 23 (5) <0.0001
Waist 1213/535 89 (12) 86 (11) 0.002 1522/470 91 (14) 88 (13) <0.0001
WHR 1213/535 0.92 (0.07) 0.92 (0.06) 0.24 1521/470 0.88(0.08) 0.90 (0.06) <0.0001
Figure 5 Age trends in obesity by ethnicity.
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(7.5%), for ≥8 mmol/L this was 84 cases (8.5%) and for
≥7 mmol/L this was 180 cases (10.8%). At the least con-
servative threshold for diabetes (≥7 mmol/L) almost half
of cases (42%) were receiving treatment.
Discussion
This large survey in Kenya highlighted the high preva-
lence of CVD risk markers, particularly in urban areas.
SES was a more important mediator of the association
between the individual CVD risk markers and urban sta-
tus than health behavior or other CVD markers. How-
ever, the urban-rural differences in hypertension and
obesity were not explained fully after adjustment for
SES, obesity, smoking, alcohol or other CVD risk
markers. The prevalence of CVD risk markers was
higher among Kikuyus than among Kalenjins. Again,
these associations were not fully explained after adjust-
ment for the possible confounders, including urban sta-
tus. A high degree of clustering of these risk markers
was apparent, both geographically and within indivi-
duals. The clustering within individuals was more
marked among rural dwellers and Kalenjins, although
they had fewer people with risk factors overall, poten-
tially indicating that there were a few early adopters of
these multiple risk factors compared to the more well
established presence among urban dwellers and Kikuyus.
Only 15% of people with hypertensive were receiving
treatment, and this was particularly low among poorer
Figure 6 Age trends in hypertension by ethnicity.
Figure 7 Age trends in diabetes by ethnicity.
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Figure 8 Age trends in systolic and diastolic blood pressure by ethnicity.
Table 4 Rural-urban differences in the prevalence of CVD risk markers
Urban
(n = 1431)
Rural
(n = 2945)
Age and sex
adjusted OR
(95% CI)
Age, sex and socio-
demographic adjusted
OR (SES score)
Age, sex, BMI,
WHR, smoking,
alcohol
Age, sex,
diabetes,
cholesterol,
hypertension
Fully
adjusted
model
Hypertension 812 (57%) 1379 (47%) 1.7 (1.5-1.9) 1.4 (1.2-1.6) 1.4 (1.2-1.6) 1.6 (1.4-1.8) 1.3 (1.1-1.5)
Normotensive 619 (43%) 1566 (53%) Baseline Baseline Baseline Baseline Baseline
Diabetic 139 (10.0%) 144 (5.0%) 2.3 (1.8-2.9) 1.3 (1.0-1.7) 2.0 (1.5-2.5) 2.2 (1.7-2.8) 1.3 (0.9-1.7)
Normal 1256 (90.0%) 2756 (95.0%) Baseline Baseline Baseline Baseline Baseline
High
cholesterol
316 (22%) 588 (21%) 1.2 (1.0-1.4) 0.9 (0.8-1.1) 1.0 (0.9-1.2) 1.1 (0.9-1.3) 0.9 (0.7-1.1)
Normal
cholesterol
1100 (78%) 2268 (79%) Baseline Baseline Baseline Baseline Baseline
Obese 287 (20%) 280 (10%) 2.3 (1.9-2.8) 1.3 (1.0-1.6) 2.9 (2.3-3.5) 2.2 (1.8-2.7) 1.5 (1.2-1.9)
Not obese 1131 (80%) 2648 (90%) Baseline Baseline Baseline Baseline Baseline
Table 5 Kikuyu-Kalenjin differences in the prevalence of CVD risk markers
Kikuyus Kalenjins Age and sex
adjusted OR
(95% CI)
Age, sex and socio-
demographic adjusted OR
(SES score and urban)
Age, sex, BMI,
WHR,
smoking,
alcohol
Age, sex,
diabetes,
cholesterol,
hypertension
Fully
adjusted
model
Hypertension 1445 (53%) 420 (42%) 1.6 (1.4-1.8) 1.3 (1.1-1.5) 1.5 (1.3-1.8) 1.5 (1.3-1.7) 1.4 (1.2-1.7)
Normotensive 1304 (47%) 588 (58%) Baseline Baseline Baseline Baseline Baseline
Diabetic 219 (8%) 24 (2%) 3.4 (2.2-5.3) 2.2 (1.4-3.4) 3.4 (2.2-5.4) 3.3 (2.2-5.2) 2.3 (1.5-3.8)
Normal 2506 (92%) 940 (98%) Baseline Baseline Baseline Baseline Baseline
High
cholesterol
648 (24%) 142 (14%) 1.8 (1.5-2.2) 1.6 (1.3-2.0) 1.6 (1.3-2.0) 1.7 (1.4-2.1) 1.5 (1.2-1.9)
Normal
cholesterol
2025 (76%) 848 (86%) Baseline Baseline Baseline Baseline Baseline
Obese 392 (14%) 80 (8%) 1.8 (1.4-2.3) 1.0 (0.8-1.3) 2.0 (1.5-2.7) 1.7 (1.3-2.2) 1.0 (0.7-1.4)
Not obese 2334 (86%) 923 (92%) Baseline Baseline Baseline Baseline Baseline
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people or rural dwellers. In contrast, more than two
thirds of people with diabetes were receiving treatment,
although this proportion fell if a lower blood glucose
threshold was used for diagnosis of diabetes.
The urban-rural differences in CVD risk markers are
likely to be explained by differences in health behavior,
including diet and physical activity. These urban-rural
differences in lifestyle may in turn explain some of the
differences in CVD risk markers between Kikuyus and
Kalenjins. However, Kikuyu and Kalenjin participants
clearly differed in physical characteristics, such as
height, weight and waist and hip circumferences, and
these may exert metabolic consequences [30], and
explain some of the differences in CVD risk markers.
The prevalence of hypertension in men in our survey
was generally high compared to other world regions, and
exceeded the prevalence in the Established Market
Economies and Latin American Countries for the oldest
age group [15]. For women in our survey the pattern was
more typical to that seen in the sub-Saharan Africa
Table 6 Clustering of risk markers by rural-urban status and ethnicity
No. of risk markers* Total group Urban Rural Kikuyu Kalenjin
Exp** Obs O:E Exp** Obs O:E Exp** Obs O:E Exp** Obs O:E Exp** Obs O:E
0 32.0 37.0 116 24.1 30.0 124 36.3 40.4 111 28.3 33.1 117 44.8 47.0 105
1 47.7 40.1 84 47.4 38.6 81 47.1 40.9 87 47.6 40.3 85 44.6 40.8 92
2 17.9 18.5 103 23.8 24.9 104 15.0 15.3 102 20.8 21.3 102 9.9 10.7 108
3-4 2.3 4.5 193 4.4 6.5 148 1.5 3.5 228 3.2 5.2 165 0.7 1.6 233
Χ2 (3 df) 71.6 P < 0.0001 27.0 p < 0.0001 39.3 p < 0.0001 40.3 p < 0.0001 6.2 p = 0.10
*Hypertension, obesity, diabetes and high cholesterol.
**Based on random assortment of four risk marker.
Table 7 Treatment for hypertension and diabetes
Hypertension Diabetes
Drug
treatment *
No
treatment
%
untreated
Multivariate adjusted OR
(95% CI)***
Treatment** No
treatment
%
untreated
Multivariate adjusted OR
(95% CI) ***
Number 323 1868 196 91
Rural 191 621 76% Baseline 86 59 41% Baseline
Urban 132 1247 90% 1.6 (1.2-2.1) 110 32 23% 2.0 (1.1-3.8)
Language
Kikuyu 232 1213 84% Baseline 152 69 31% Baseline
Kalenjin 20 400 95% 0.5 (0.3-0.8) 15 10 40% 0.9 (0.3-2.1)
Other 72 255 78% 1.3 (0.9-1.8) 29 12 29% 0.9 (0.4-2.0)
Age
50-59 128 726 85% Baseline 67 40 37% Baseline
60-69 107 561 84% 1.7 (1.2-2.3) 74 29 28% 1.9 (1.0-3.5)
70-79 57 357 86% 2.0 (1.4-3.0) 34 12 26% 3.3 (1.4-7.9)
≥80 31 224 88% 2.0 (1.2-3.3) 21 10 32% 2.6 (0.9-7.3)
Male 93 923 91% Baseline 92 47 34% Baseline
Female 230 945 80% 3.4 (2.5-4.5) 104 44 30% 1.8 (1.0-3.1)
SES score
1
(poorest)
23 456 95% Baseline 14 11 44% Baseline
2 39 456 92% 1.4 (0.8-2.3) 19 22 54% 0.7 (0.3-2.1)
3 87 493 85% 2.7 (1.7-4.4) 60 24 29% 2.3 (0.9-5.9)
4 (richest) 169 456 73% 4.7 (2.9-7.7) 102 33 24% 2.2 (0.8-5.8)
Schooling
Any 249 1217 83% 1.3 (1.1-1.5) 41 24 37% 1.2 (0.8-1.8)
None 74 651 90% Baseline 155 67 30% Baseline
*Treatment for hypertension included drug treatment only.
**Treatment for diabetes included insulin, tablets or diet control.
*** Adjusted for age, sex, urban/rural, ethnic group, SES score, schooling.
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region. Other studies from Africa confirm the higher pre-
valence of hypertension, diabetes and obesity in urban
compared to rural populations [11,12,14,16,17,19,39].
Previous surveys confirm our finding of a higher preva-
lence of obesity among women compared to men in
Africa [12-14], and suggest that BMI differences between
rural and urban areas drive differences in diabetes preva-
lence [39]. Few people with hypertension were currently
treated in the Nakuru survey, which is consistent with
the findings from other African settings [7,17,40], while
the proportion of people with diabetics receiving treat-
ment was higher than in other surveys [39].
The high prevalence of CVD markers in Nakuru, par-
ticularly hypertension, is likely to be of substantial pub-
lic health importance, as untreated hypertension is an
important modifiable risk factor for stroke in Africa
[7,41]. This is compounded by the low proportion of
hypertensives receiving treatment in this population,
although the situation was better for diabetes. The rise
of non communicable diseases are likely to put further
pressure on an already overstretch primary health care
system [9], and so prevention is important potentially
through reducing obesity and salt intake [23,42,43].
Further studies investigating means of reducing hyper-
tension in Africa are needed urgently [44].
There were a number of limitations to this study. The
study design was a cross-sectional survey, and so we
could not take account of the temporal relationship
between potential risk markers and outcomes. We mea-
sured blood pressure on only one day and so regression
to the mean was possible, and one cuff size was used for
all participants. The blood glucose measures were
obtained from non-fasting blood samples, rather than
through use of the oral glucose tolerance test or fasting
blood glucose, and this may have underestimated the
prevalence of diabetes. Lowering the threshold blood
glucose level cut-off for the definition of diabetes
increased the prevalence, however, this was not substan-
tial until the level was reduced to >7 mmol/L. We mea-
sured smoking and alcohol status, but we did not assess
physical activity or diet or other blood markers (e.g.
renin), which were potentially important explanatory
variables. Although we measured BMI and WHR, it
would have been useful to include bioimpedance as a
measure of body fat. Classifying people as “Kikuyu” or
“Kalenjin” on the basis of their mother tongue may have
been over-simplistic. This study also had important
strengths. There was a high response rate, and the sam-
ple was representative across Nakuru, limiting the
impact of selection bias. We included a measure of SES
which was previously validated for this area [37]. The
measures of blood pressure and anthropometry were
assessed by trained medical staff.
Conclusions
The burden of CVD risk markers is high in Kenya, par-
ticularly in urban areas. Exploring differences in CVD
risk markers between ethnic groups may help us to elu-
cidate the epidemiology of these conditions in Africa.
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